Table 1

Patient Baseline Characteristics

TAVR Group
(n = 391)
Surgical Group
(n = 359)
p Value
Age, yrs83.2 ± 7.183.3 ± 6.30.80
Male207/391 (52.9)188/359 (52.4)0.88
NYHA functional class0.71
 II57/391 (14.6)47/359 (13.1)
 III255/391 (65.2)250/359 (69.6)
 IV79/391 (20.2)62/359 (17.3)
STS PROM score, %7.3 ± 3.07.5 ± 3.30.34
STS PROM score0.57
 <4%33/391 (8.4)40/359 (11.1)
 4%–10%304/391 (77.7)253/359 (70.5)
 >10%54/391 (13.8)66/359 (18.4)
Logistic EuroSCORE, %17.7 ± 13.018.8 ± 13.20.24
Diabetes mellitus136/391 (34.8)162/359 (45.1)0.004
Controlled by insulin43/391 (11.0)47/359 (13.1)0.38
Chronic kidney disease (stage 4/5)48/387 (12.4)45/354 (12.7)0.90
History of hypertension372/391 (95.1)345/359 (96.1)0.52
Peripheral vascular disease159/388 (41.0)150/357 (42.0)0.77
Previous stroke49/391 (12.5)50/358 (14.0)0.56
Previous TIA50/391 (12.8)48/358 (13.4)0.80
Cardiac risk factors
 Coronary artery disease295/391 (75.4)273/359 (76.0)0.85
 Previous CABG115/391 (29.4)113/359 (31.5)0.54
 Previous PCI134/391 (34.3)135/359 (37.6)0.34
 Pre-existing pacemaker91/391 (23.3)76/359 (21.2)0.49
 Previous myocardial infarction99/391 (25.3)91/359 (25.3)0.99
 Congestive heart failure373/391 (95.4)347/359 (96.7)0.38
 Previous atrial fibrillation/atrial flutter160/390 (41.0)165/359 (46.0)0.17

Values are mean ± SD or n/N (%).

CABG = coronary artery bypass graft; EuroSCORE = European System for Cardiac Operative Risk Evaluation; NYHA = New York Heart Association; PCI = percutaneous coronary intervention; STS PROM = Society of Thoracic Surgeons predictors of mortality; TAVR = transcatheter aortic valve replacement; TIA = transient ischemic attack.